生物膜修饰生物仿真纳米药物输送系统:心血管疾病治疗的前沿平台
Yunan Gu1, Lixin Du1, Yuxin Wu1
1School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Biomolecules
|August 29, 2024
概括
生物膜修饰生物模拟纳米药物递送系统 (BNDS) 提供了更好的生物相容性和针对心血管疾病 (CVD) 的向. 这些纳米药物在克服当前心血管疾病治疗的局限性方面表现有前途.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 心血管研究研究心血管研究
背景情况:
- 心血管疾病 (CVD) 仍然是全球主要的死亡原因.
- 目前对心血管疾病的药物治疗面临诸多挑战,包括针对性不佳和显著的副作用.
- 纳米医学为心血管疾病提供了新的治疗策略,生物膜修饰生物模拟纳米药物递送系统 (BNDS) 特别有前途.
研究的目的:
- 审查心血管疾病的分类和病理学.
- 系统地总结BNDS在心脏病治疗中的研究进展.
- 讨论针对心血管疾病的BNDS的设计,功能和临床潜力.
主要方法:
- 在心血管疾病中纳米医学应用的文献综述.
- 对纳米药物输送系统的生物膜修改策略的分析.
- 评估BNDS的生物相容性,准效率和体内性能.
主要成果:
- 通过逃避免疫系统清除,BNDS表现出增强的生物相容性和延长的循环时间.
- 生物膜修饰改善了对受影响的心血管组织的药物向.
- BNDS显示出克服传统心血管疾病治疗的局限性的潜力.
结论:
- 在纳米医学中,BNDS代表了治疗心血管疾病的有希望的进步.
- 需要进一步的研究和开发,以应对BNDSs临床转化方面的挑战.
- 在心血管医学中,BNDS具有改善治疗结果的巨大潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


